Laura Hammitt
Denver, CONPI 1659427276
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,380 of the $7,064 with a category attached, or 90.3%. Every reported general payment came from a single manufacturer, Merck.
Across 7 payments — averaging $1009.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$7K
Across 203 payments — averaging $23,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$3.5M
- Pfizer$1M
- AstraZeneca$299K
- Sanofi Pasteur Inc.$27K
What the payments were for
- Consulting fees$6,38090%
- Travel & lodging$4346%
- Food & beverage$2494%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 7 | $7,064 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPVAXIVE$399
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.